Literature DB >> 31879605

Prone ventilation in H1N1 virus-associated severe acute respiratory distress syndrome: A case series.

Jyoti Narayan Sahoo1, Mohan Gurjar2, Krantimaya Mohanty1, Kalpana Majhi1, G Sradhanjali1.   

Abstract

BACKGROUND: Management of H1N1 viral infection-associated acute respiratory distress syndrome (ARDS) has primarily been focused on lung protective ventilation strategies, despite that mortality remains high (up to 45%). Other measures to improve survival are prone position ventilation (PPV) and extracorporeal membrane oxygenation. There is scarcity of literature on the use of prone ventilation in H1N1-associated ARDS patients.
METHODS: In this retrospective study, all adult patients admitted to medical intensive care unit (ICU) with H1N1 viral pneumonia having severe ARDS and requiring prone ventilation as a rescue therapy for severe hypoxemia were reviewed. The patients were considered to turn prone if PaO2/FiO2 ratio was <100 cmH2O and PaCO2 was >45 cmH2O; if no progressive improvement was seen in PaO2/FiO2 over a period of 4 h, then patients were considered to turn back to supine. Measurements were obtained in supine (baseline) and PPV, after 30-60 min and then 4-6 hourly.
RESULTS: Eleven adult patients with severe ARDS were ventilated in prone position. Their age range was 26-59 years. The worst PaO2/FiO2 ratio range on the day of invasive ventilation was 48-100 (median 79). A total of 39 PPV sessions were done, with a range of 1-8 prone sessions per patient (median three sessions). Out of the 39 PPV sessions, PaO2/FiO2 ratio and PaCO2 responder were 38 (97.4%) and 27 (69.2%) sessions, respectively. The median ICU stay and mechanical ventilation days were 15 (range: 3-26) and 12 (range: 2-22) days, respectively. The common complication observed due to PPV was pressure ulcer. At ICU discharge, all except two patients survived.
CONCLUSION: PPV improves oxygenation when started early with adequate duration and should be considered in all severe ARDS cases secondary to H1N1 viral infection. Copyright:
© 2019 International Journal of Critical Illness and Injury Science.

Entities:  

Keywords:  Acute respiratory distress syndrome; H1N1 viral infection; prone ventilation

Year:  2019        PMID: 31879605      PMCID: PMC6927129          DOI: 10.4103/IJCIIS.IJCIIS_62_18

Source DB:  PubMed          Journal:  Int J Crit Illn Inj Sci        ISSN: 2229-5151


INTRODUCTION

Post pandemic 2009 H1N1 viral infection, multiple small epidemic outbreaks have been reported worldwide.[1] Mortality up to 45% among patients admitted to intensive care units (ICUs) has been reported in a recent epidemic.[23] The main cause of death in patients with pneumonia caused by H1N1 viral infection is multiorgan failure secondary to hypoxemia because of acute respiratory distress syndrome (ARDS) and secondary bacterial infection.[45] As with other causes of ARDS, management of H1N1 viral infection ARDS is focused on lung protective ventilation (LPV) strategies, but despite that mortality remains high.[6] Other measures to improve survival include prone position ventilation (PPV) and extracorporeal membrane oxygenation (ECMO); although enough evidences showed that PPV reduces mortality (16%) compared to supine position ventilation (32.8%),[278] there are underutilization of this strategy, which is found in recent trials.[59] In addition, there is scarcity of literature on the use of prone ventilation in H1N1 ARDS patients.[101112] We studied the effect of prone ventilation in severe ARDS patients admitted with the diagnosis of H1N1 during an epidemic in the winter months of 2014–2015 in a southern state of India.

METHODS

This study was conducted at a tertiary health-care center in southern part of India. All patients admitted to medical ICU with H1N1 viral pneumonia having severe ARDS requiring prone ventilation as a rescue therapy for severe hypoxemia were reviewed prospectively. Polymerase chain reaction-confirmed H1N1 was included in this series. ARDS was defined as per the Berlin definition.[13] Patients with cardiogenic pulmonary edema and spinal instability were excluded from the study. All the included patients were studied while sedated with fentanyl and midazolam and paralyzed with atracurium. The ventilatory settings were set as per the treating physician. Positive end-expiratory pressure (PEEP) and FiO2 were adjusted according to the PEEP-FiO2 table of ARDSnet trial.[6] Measurements were obtained in supine (baseline) and PPV, after 30–60 min and then 4–6 hourly. The patients were considered to turn prone if PaO2/FiO2 ratio was <100 cmH2O and PaCO2 was >45 cmH2O. Patients were classified as nonresponders if the PaO2/FiO2 ratio does not increase by >20% and PaCO2 decrease by 6 cmH2O. In PPV, if no progressive improvement was seen in PaO2/FiO2 and PaCO2 over a period of 4 h, then the patients were considered to turn supine. In this descriptive study, parametric and nonparametric data were presented as means (standard deviation) and medians, respectively.

RESULTS

Between September 1, 2014, and March 15, 2015, 93 patients were treated for H1N1 viral pneumonia. Of these, 11 adult patients developed severe ARDS which did not responded to lung-protective ventilator strategies and were ventilated in prone position [Table 1]. Their age range was 26–59 years (median: 48), with four patients under the age of 40 years. Seven patients were female, including one postpartum. All presented with fever, cough, and dyspnea for 4–12 days. The number of days from symptom onset to invasive ventilation ranged from 7 to 12 days (median: 8). Five patients had comorbid illness, the common being morbid obesity and diabetes mellitus. On the day of ICU admission, the median Acute Physiological and Chronic Health Evaluation-II and Sequential Organ Failure Assessment scores were 20 (range: 16–27) and 7 (range: 5–12), respectively. Noninvasive ventilation trial was given in eight patients before invasive ventilation, out of which two required invasive ventilation within 12 h and the rest in 48 h. The worst PaO2/FiO2 ratio range on the day of invasive ventilation was 48–100 (median: 79). Out of 11 patients, PPV was started within 24 h in 8 patients and within 48 h in 3 patients. Preprone, ventilator, and blood gas parameters are summarized in Table 2; the response of PaO2/FiO2 ratio to prone ventilation is shown in Figure 1. Four patients had cardiac dysfunction, with one having viral myocarditis (global hypokinesia ejection fraction of 23%), and three patients had pulmonary arterial hypertension with acute right heart failure. A total of 39 PPV sessions were done, with a range of 1–8 prone sessions per patient (median: 3). A total of 580 h of prone ventilation was done with an average of 14 h 52 min/session (range: 8–24) of prone ventilation. Out of the 39 PPV sessions, PaO2/FiO2 ratio and PaCO2 responder were 38 (97.4%) and 27 (69.2%) sessions, respectively.
Table 1

Demographic and clinical characteristic of patients

Patient numberAgeGenderComorbidAt ICU admission
Days of illness before invasive ventilationSeverity of ARDS: PaO2/FiO2 ratio on the day of prone ventilationIntubation to prone ventilation in daysNumber of prone ventilation sessionsMV daysICU daysOutcome at discharge
APACHE-II scoreSOFA score
148Female-2712855141216Survived
255Female-2278100251519Survived
340FemaleDM208857031415Survived
459FemaleHTN, COPD185879151922Survived
552Male-1910775281621Survived
652MaleCKD, Ca tongue on chemotherapy241087313910Died
735Male-19512791279Survived
844FemaleDM, morbid obesity227990242226Survived
926Female-166990121214Survived
1054MaleMorbid obesity231011480133Died
1126FemalePostpartum16688212912Survived

APACHE-II score: Acute Physiological and Chronic Health Evaluation score, SOFA score: Sequential Organ Failure Assessment score, ARDS: Acute respiratory distress syndrome, PaO2/FiO2: Partial pressure of oxygen in arterial blood/fractional inspired oxygen concentration, MV: Minute ventilation, ICU: Intensive care unit, DM: Diabetes mellitus, HTN: Hypertension, COPD: Chronic obstructive pulmonary disease, CKD: Chronic kidney disease, Ca: Carcinoma

Table 2

Ventilator parameters and blood gases before the first prone session

Patient numberPBWPreprone ventilator parameters
FiO2PaO2/FiO2 ratioPCO2PEEPPlateau pressureComplianceTvLISMV
1589062491231183603.510.6
2608048581432163603.7512
3528057381231183203.510
4567010056113028340313
570807538143122420311.8
662705240123122370310.6
768658057143220400310.2
856807049143214340312.4
9527590401230193202.510.2
106010050601635143903.2513
1152808044143214339312

PBW: Predicted body weight (kg), PaO2/FiO2: Partial pressure of oxygen in arterial blood/fractional inspired oxygen concentration, PEEP: Positive end-expiratory pressure (cmH2O), Tv: Inspired tidal volume (ml), MV: Inspired minute ventilation (L/min), LIS: Lung injury score

Figure 1

Changes in PaO2/FiO2 ratio in response to prone position ventilation session. Supine PaO2/FiO2: Before prone position; prone PaO2/FiO2: End of prone position ventilation

Demographic and clinical characteristic of patients APACHE-II score: Acute Physiological and Chronic Health Evaluation score, SOFA score: Sequential Organ Failure Assessment score, ARDS: Acute respiratory distress syndrome, PaO2/FiO2: Partial pressure of oxygen in arterial blood/fractional inspired oxygen concentration, MV: Minute ventilation, ICU: Intensive care unit, DM: Diabetes mellitus, HTN: Hypertension, COPD: Chronic obstructive pulmonary disease, CKD: Chronic kidney disease, Ca: Carcinoma Ventilator parameters and blood gases before the first prone session PBW: Predicted body weight (kg), PaO2/FiO2: Partial pressure of oxygen in arterial blood/fractional inspired oxygen concentration, PEEP: Positive end-expiratory pressure (cmH2O), Tv: Inspired tidal volume (ml), MV: Inspired minute ventilation (L/min), LIS: Lung injury score Changes in PaO2/FiO2 ratio in response to prone position ventilation session. Supine PaO2/FiO2: Before prone position; prone PaO2/FiO2: End of prone position ventilation The median ICU stay and mechanical ventilation days were 15 (range: 3–26) and 12 (range: 2–22) days, respectively. In five patients, tracheal aspirate showed bacterial growth (3 – Acinetobacter baumannii, 1 – Pseudomonas aeruginosa, and 1 – Klebsiella pneumoniae) and all survived. Apart from respiratory failure, two patients required vasopressor therapy and two had cardiovascular and renal failure, of which both patients died. Seven patients were tracheotomized. The median duration of spontaneous breathing trial from the day of prone ventilation was 8 (range: 5-16) days. The complications were observed as pressure ulcer in four patients; while back pain and critical illness neuromyopathy in one each patient. Two patients died due to shock and multiorgan failure.

DISCUSSION

In this single-center, retrospective observational study, all H1N1 infection-associated severe ARDS patients showed improvement in PaO2/FiO2 ratio (>20%) after the first prone session, with many of them undergoing multiple prone sessions also. There are multiple factors which may account for the benefit in PPV such as reduction in dependent atelectasis and pleural pressure gradient,[14] alveolar recruitment,[15] homogeneous ventilation,[16] and relief of the compressive segment of the lung by the heart[1718] and abdomen.[19] All these factors cause reduction in ventilation and perfusion mismatch, intrapulmonary shunt, and ventilator-induced lung injury (VILI). These all lead to improved oxygenation and decreased PaCO2. The oxygenation and PaCO2 response to PPV are variable and depend on the type of lung injury, percentage of recruitable lung tissue,[20] and duration of PPV.[421] Patients with diffuse lung injury have less nonaerated lung tissue and respond to prone ventilation by increase in oxygenation without decrease in PaCO2, whereas lobar lung injury has significant percentage of nonaerated recruitable lung tissue and shows marked decrease in PaCO2 along with improvement in oxygenation.[15] Alveolar recruitment in PPV is time dependent, with different nonaerated lung units having different plateaus for complete alveolar recruitment.[22] Till 2013, a large number of randomized controlled trials were published which did not show any mortality benefit of PPV in ARDS patients, although improvement of oxygenation was seen.[21232425262728] Many reasons have been put forth for nonimprovement in mortality in earlier studies such as lack of power in the study, too short PPV, heterogeneous patient population, or improved oxygenation does not translate to decrease mortality as multiorgan failure being the most common cause of mortality followed by hypoxemia in ALI or ARDS patients.[2930] We studied the effect of prone ventilation in severe ARDS due to H1N1, with early initiation, prolonged duration, and multiple sessions. Our study replicated the findings of Guérin et al. regarding the beneficial effect of PPV in severe ARDS when started early with prolonged duration.[8] Worldwide, ARDS is associated with substantial mortality, with unadjusted ICU and hospital mortality of 35.3% (95% confidence interval [CI], 33.3%–37.2%) and 40.0% (95% CI, 38.1%–42.1%), respectively.[5] H1N1 viral infection ARDS causes 36%–38% mortality in accordance with other causes of ARDS.[331] Overall, worldwide, PPV is used in 7.9% (95% CI, 6.8–9) in all patients and 16.3% (95% CI 13.7–19.2) in severe ARDS patients.[5] As with other causes of ARDS, management of H1N1 viral infection ARDS is focused on LPV strategies, and PPV is a very safe and effective way of achieving improved oxygenation and preventing VILI.[1232] In recent published trials worldwide on severe H1N1 viral ARDS, only 20%, 45%, 34%, 28%, and 47% of patients were subjected to prone position ventilated before starting ECMO in Australian, French, UK, Italian, and German studies, respectively.[2373133] Our study differs from that of previous with regard to the optimal duration of PPV. Earlier studies with prone ventilation used short duration PPV (8 h) with no mortality benefit,[2324] but later studies which used longer duration PPV showed mortality benefit when used in severe ARDS patients with high percentage of nonaerated lung unit.[821] In our studies, we used variable PPV duration (average: 14 h 52 min, range: 8–24 h) and continued until we did not find any improvement in oxygenation, decrease in PaCO2, or increase in tidal volume over a period of 4 h. In the present study, according to clinician's decision, multiple prone sessions were considered till PaO2/FiO2 ratio sustained >150 in supine position. One patient had only one prone session, and later he died [Figure 1].

CONCLUSION

Our study demonstrates that PPV improves oxygenation when started early with adequate duration and should be considered in all severe ARDS cases secondary to H1N1 viral infection.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

Ethical conduct of research

This study was approved by the Institutional Review Board / Ethics Committee. The authors followed applicable EQUATOR Network (http://www.equator-network.org/) guidelines during the conduct of this research project.
  33 in total

1.  The prone position eliminates compression of the lungs by the heart.

Authors:  R K Albert; R D Hubmayr
Journal:  Am J Respir Crit Care Med       Date:  2000-05       Impact factor: 21.405

Review 2.  Ventilator-induced lung injury.

Authors:  Arthur S Slutsky; V Marco Ranieri
Journal:  N Engl J Med       Date:  2013-11-28       Impact factor: 91.245

3.  Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries.

Authors:  Giacomo Bellani; John G Laffey; Tài Pham; Eddy Fan; Laurent Brochard; Andres Esteban; Luciano Gattinoni; Frank van Haren; Anders Larsson; Daniel F McAuley; Marco Ranieri; Gordon Rubenfeld; B Taylor Thompson; Hermann Wrigge; Arthur S Slutsky; Antonio Pesenti
Journal:  JAMA       Date:  2016-02-23       Impact factor: 56.272

4.  Prone positioning in severe acute respiratory distress syndrome.

Authors:  Claude Guérin; Jean Reignier; Jean-Christophe Richard; Pascal Beuret; Arnaud Gacouin; Thierry Boulain; Emmanuelle Mercier; Michel Badet; Alain Mercat; Olivier Baudin; Marc Clavel; Delphine Chatellier; Samir Jaber; Sylvène Rosselli; Jordi Mancebo; Michel Sirodot; Gilles Hilbert; Christian Bengler; Jack Richecoeur; Marc Gainnier; Frédérique Bayle; Gael Bourdin; Véronique Leray; Raphaele Girard; Loredana Baboi; Louis Ayzac
Journal:  N Engl J Med       Date:  2013-05-20       Impact factor: 91.245

5.  Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome.

Authors:  Roy G Brower; Michael A Matthay; Alan Morris; David Schoenfeld; B Taylor Thompson; Arthur Wheeler
Journal:  N Engl J Med       Date:  2000-05-04       Impact factor: 91.245

6.  Role of the heart in the loss of aeration characterizing lower lobes in acute respiratory distress syndrome. CT Scan ARDS Study Group.

Authors:  L M Malbouisson; C J Busch; L Puybasset; Q Lu; P Cluzel; J J Rouby
Journal:  Am J Respir Crit Care Med       Date:  2000-06       Impact factor: 21.405

7.  Update: novel influenza A (H1N1) virus infections - worldwide, May 6, 2009.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2009-05-08       Impact factor: 17.586

8.  Extracorporeal Membrane Oxygenation for 2009 Influenza A(H1N1) Acute Respiratory Distress Syndrome.

Authors:  Andrew Davies; Daryl Jones; Michael Bailey; John Beca; Rinaldo Bellomo; Nikki Blackwell; Paul Forrest; David Gattas; Emily Granger; Robert Herkes; Andrew Jackson; Shay McGuinness; Priya Nair; Vincent Pellegrino; Ville Pettilä; Brian Plunkett; Roger Pye; Paul Torzillo; Steve Webb; Michael Wilson; Marc Ziegenfuss
Journal:  JAMA       Date:  2009-10-12       Impact factor: 56.272

9.  A multicenter trial of prolonged prone ventilation in severe acute respiratory distress syndrome.

Authors:  Jordi Mancebo; Rafael Fernández; Lluis Blanch; Gemma Rialp; Federico Gordo; Miquel Ferrer; Fernando Rodríguez; Pau Garro; Pilar Ricart; Immaculada Vallverdú; Ignasi Gich; José Castaño; Pilar Saura; Guillermo Domínguez; Alfons Bonet; Richard K Albert
Journal:  Am J Respir Crit Care Med       Date:  2006-03-23       Impact factor: 21.405

10.  The Italian ECMO network experience during the 2009 influenza A(H1N1) pandemic: preparation for severe respiratory emergency outbreaks.

Authors:  Nicolò Patroniti; Alberto Zangrillo; Federico Pappalardo; Adriano Peris; Giovanni Cianchi; Antonio Braschi; Giorgio A Iotti; Antonio Arcadipane; Giovanna Panarello; V Marco Ranieri; Pierpaolo Terragni; Massimo Antonelli; Luciano Gattinoni; Fabrizio Oleari; Antonio Pesenti
Journal:  Intensive Care Med       Date:  2011-07-06       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.